Light-activatable gold nanoshells for drug delivery applications

AAPS PharmSciTech

Volumn 15, Issue 3, 2014, Pages 741-752

  Singhana, Burapol ^a,b   Slattery, Patrick ^c   Chen, Aaron ^d   Wallace, Michael ^a   Melancon, Marites P ^a,e  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b NAKHON PHANOM UNIVERSITY   (Thailand)

^c Northeast Ohio Medical University   (United States)

^d UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF TEXAS   (United States)

Author keywords

drug delivery; gold nanoshells; nanocarrier; theranostics; triggered release

Indexed keywords

ANTIBODY; APTAMER; CETUXIMAB; DOXORUBICIN; GOLD NANOSHELL; LIGAND; NANOCARRIER; NANOSHELL; PACLITAXEL; PEPTIDE DERIVATIVE; SINGLE STRANDED DNA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; DELAYED RELEASE FORMULATION; DRUG CARRIER; GOLD;

BIOCOMPATIBILITY; DIAGNOSTIC IMAGING; DRUG DELIVERY SYSTEM; GENE DELIVERY SYSTEM; HUMAN; HYPERTHERMIA; IMMUNOGENICITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SURFACE PLASMON RESONANCE; TARGET CELL; ANIMAL; CHEMISTRY; DELAYED RELEASE FORMULATION; GENE THERAPY; GENE TRANSFER; LIGHT; MEDICINAL CHEMISTRY; MOLECULARLY TARGETED THERAPY; NANOMEDICINE; PHARMACEUTICS; PROCEDURES; RADIATION RESPONSE;

ANIMALS; ANTINEOPLASTIC AGENTS; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; GENE TRANSFER TECHNIQUES; GENETIC THERAPY; GOLD; HUMANS; LIGHT; MOLECULAR TARGETED THERAPY; NANOMEDICINE; NANOSHELLS; TECHNOLOGY, PHARMACEUTICAL;

EID: 84901985112     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-014-0097-8     Document Type: Review

References (54)

1. Link S, El-Sayed MA. Optical properties and ultrafast dynamics of metallic nanocrystals. Annu Rev Phys Chem. 2003;54:331-6.
2. Halas NJ, Lal S, Link L, Chang W-S, Natelson D, Hafner JH, et al . A plethora of plasmonics from the laboratory for nanophotonics at Rice University. Adv Mater. 2012;24:4842-77.
3. Bardhan R, Lal S, Joshi A, Halas NJ. Theranostic nanoshells: from probe design to imaging and treatment of cancer. Acc Chem Res. 2011;44:936-46.
4. Weissleder R. A clearer vision for in vivo imaging. Nat Biotechnol. 2001;19:316-7.
5. Hirsch LR, Stafford RJ, Bankson JA, Sershen SR, Rivera B, Price RE, et al. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. P Natl Acad Sci. 2003;100:13549-54. (Pubitemid 37444779)
6. Lal S, Clare SE, Halas NJ. Nanoshell-enabled photothermal cancer therapy: impending clinical impact. Acc Chem Res. 2008;41:1842-51.
7. Melancon MP, Zhou M, Li C. Cancer theranostics with near-infrared light-activatable multimodal nanoparticles. Acc Chem Res. 2011;44:947-56.
8. Barhoumi A, Huschka R, Bardhan R, Knight MW, Halas NJ. Light-induced release of DNA from plasmon-resonant nanoparticles: towards light-controlled gene therapy. Chem Phys Lett. 2009;482:171-9.
9. Braun GB, Pallaoro A, Wu G, Missirlis D, Zasadzinski JA, Tirrell M, et al. Laser-activated gene silencing via gold nanoshell-siRNA conjugates. ACS Nano. 2009;3:2007-15.
10. Zhao N, You J, Zeng Z, Li C, Zu Y. An ultra pH-sensitive and aptamer-equipped nanoscale drug-delivery system for selective killing of tumor cells. Small. 2013;9:3477-84.
11. Lu W, Zhang G, Zhang R, Flores II LG, Huang Q, Gelovani JG, et al. Tumor site-specific silencing of NF-κB p65 by targeted hollow gold nanosphere - mediated photothermal transfection. Cancer Res. 2010;70:3177-88.
12. Zhang Z, Wang J, Chen C. Near-infrared light-mediated nanoplatforms for cancer thermo-chemotherapy and optical imaging. Adv Mater. 2013;25:3869-80.
13. Alexander-Bryant AA, Vanden Berg-Foels WS, Wen X. Bioengineering strategies for designing targeted cancer therapies. Adv Cancer Res. 2013;118:1-59.
14. Kievit FM, Zhang M. Cancer nanotheranostics: improving imaging and therapy by targeted delivery across biological barriers. Adv Mater. 2011;23:H217-47.
15. Cheng Z, Zaki AA, Hui JZ, Muzykantov VR, Tsourkas A. Multifunctional nanoparticles: cost versus benefit of adding targeting and imaging capabilities. Science. 2012;338:903-10.
16. Shi J, Votruba AR, Farokhzad OC, Langer R. Nanotechnology in drug delivery and tissue engineering: from discovery to applications. Nano Lett. 2010;10:3223-30.
17. Huschka R, Neumann O, Barhoumi A, Halas NJ. Visualizing light-triggered release of molecules inside living cells. Nano Lett. 2010;10:4117-22.
18. You J, Zhang G, Li C. Exceptionally high payload of doxorubicin in hollow gold nanospheres for near-infrared light-triggered drug release. ACS Nano. 2010;4:1033-41.
19. You J, Zhang R, Zhang G, Zhong M, Liu Y, Van Pelt CS, et al. Photothermal chemotherapy with doxorubicin-loaded hollow gold nanospheres: a platform for near-infrared light-trigged drug release. J Control Release. 2012;158:319-28.
20. You J, Shao R, Wei X, Gupta S, Li C. Near-infrared light triggers release of paclitaxel from biodegradable microspheres: photothermal effect and enhanced antitumor activity. Small. 2010;6:1022-31.
21. Jin Y. Multifunctional compact hybrid Au nanoshells: a new generation of nanoplasmonic probes for biosensing, imaging, and controlled release. Acc Chem Res. 2013. doi:10.1021/ar400086e.
22. Xia X, Wang Y, Ruditskiy A, Xia Y. 25th Anniversary article: galvanic replacement: a simple and versatile route to hollow nanostructures with tunable and well-controlled properties. Adv Mater. 2013;25:6313-33.
23. Boisselier E, Astruc D. Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies, and toxicity. Chem Soc Rev. 2009;38:1759-82.
24. Eustis S, El-Sayed MA. Why gold nanoparticles are more precious than pretty gold: noble metal surface plasmon resonance and its enhancement of the radiative and nonradiative properties of nanocrystals of different shapes. Chem Soc Rev. 2006;35:209-17. (Pubitemid 43327142)
25. Dreaden EC, Mackey MA, Huang X, Kangy B, El-Sayed MA. Beating cancer in multiple ways using nanogold. Chem Soc Rev. 2011;40:3391-404.
26. 2S nanoshells: insight into multicomponent nanoparticle growth. Phys Rev Lett. 1997;78:4217-20.
27. Oldenberg SJ, Averitt RD, Westcott SL, Halas NJ. Nanoengineering of optical resonances. Chem Phys Lett. 1998;288:243-7. (Pubitemid 128185622)
28. Loo C, Lin A, Hirsch L, Lee M-H, Barton J, Halas NJ, et al. Nanoshell-enabled photonics-based imaging and therapy of cancer. Technol Cancer Res Treat. 2004;3:33-40. (Pubitemid 38250466)
29. Chen W, Bardhan R, Bartels M, Perez-Torres C, Pautler RG, Halas NJ, et al. A Molecularly targeted theranostic probe for ovarian cancer. Mol Cancer Ther. 2010;9:1028-38.
30. Liang HP, Wan LJ, Bai CL, Jiang L. Gold hollow nanospheres: tunable surface plasmon resonance controlled by interior-cavity sizes. J Phys Chem B. 2005;109:7795-800. (Pubitemid 40643999)
31. Prevo BG, Esakoff SA, Mikhailovsky A, Zasadzinski JA. Scalable routes to gold nanoshells with tunable sizes and response to near-infrared pulsed-laser irradiation. Small. 2008;4:1183-95.
32. Ji XJ, Shao RP, Elliott AM, Stafford RJ, Esparza-Coss E, Bankson JA, et al. Bifunctional gold nanoshells with a superparamagnetic iron oxide-silica core suitable for both MR imaging and photothermal therapy. J Phys Chem C. 2007;111:6245-51. (Pubitemid 46787841)
33. Nandwana V, Elkins KE, Poudyal N, Chaubey GS, Yano K, Liu JP. Size and shape control of monodisperse FePt nanoparticles. J Phys Chem C. 2007;111:4185-9. (Pubitemid 46548827)
34. Yang J, Lee J, Kang J, Oh SJ, Ko H-J, Son J-H, et al. Smart drug-loaded polymer gold nanoshells for systemic and localized therapy of human epithelial cancer. Adv Mater. 2009;21:4339-42.
35. 4 core@hybrid@Au shell nanocomposite for bimodal imaging and photothermal therapy. Adv Mater. 2011;23:5392-7.
36. Jin YD, Gao XH. Plasmonic fluorescent quantum dots. Nat Nanotechnol. 2009;4:571-6.
37. Jin Y, Gao X. Spectrally tunable leakage-free gold nanocontainers. J Am Chem Soc. 2009;131:17774-6.
38. Kamaly N, Xiao Z, Valencia PM, Radovic-Moreno AF, Farokhzad OC. Targeted polymeric therapeutic nanoparticles: design, development and clinical translation. Chem Soc Rev. 2012;47:2971-3010.
39. Melancon MP, Stafford RJ, Li C. Challenges to effective cancer nanotheranostics. J Control Release. 2012;164:177-82.
40. Lu W, Xiong C, Zhang G, Huang Q, Zhang R, Cheng JZ, et al. Targeted photothermal ablation of murine melanomas with melanocyte-stimulating hormone analog-conjugated hollow gold nanospheres. Clin Cancer Res. 2009;15:876-86.
41. Lee HJ, Liu Y, Zhao J, Zhou M, Bouchard RR, Mitcham T, et al. In vitro and in vivo mapping of drug release after laser ablation thermal therapy with doxorubicin-loaded hollow gold nanoshells using fluorescence and photoacoustic imaging. J Control Release. 2013;172:152-8.
42. Nagamitsu A, Greish K, Maeda H. Elevating blood pressure as a strategy to increase tumor-targeted delivery of macromolecular drug SMNCS: cases of advanced solid tumors. Jpn J Clin Oncol. 2009;39:756-66.
43. Love JC, Kriebel JK, Nuzzo RG, Whitesides GM. Self-assembled monolayers of thiolates on metals as a form of nanotechnology. Chem Rev. 2005;105:1103-69. (Pubitemid 40600878)
44. Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol. 2007;2:751-60. (Pubitemid 350223348)
45. Herbst RS. Review of epidermal growth factor receptor biology. Int J Radiat Oncol Biol Phys. 2004;59:S21-6.
46. You J, Zhang R, Xiong C, Zhong M, Melancon MP, Gupta S, et al. Effective photothermal chemotherapy using doxorubicin loaded gold nanospheres that target EphB4 receptors in tumors. Cancer Res. 2012;72:4777-86.
47. Huschka R, Zuloaga J, Knight MW, Brown LV, Nordlander P, Halas NJ. Light-induced release of DNA from gold nanoparticles: nanoshells and nanorods. JAmChem Soc. 2011;133:12247-55.
48. Neto BAD, Lapis AAM. Recent developments in the chemistry of deoxyribonucleic acid (DNA) intercalators: principles, design, synthesis, applications and trends. Molecules. 2009;14:1725-46.
49. Huschka R, Barhoumi A, Liu Q, Roth JA, Ji L, Halas NJ. Gene silencing by gold nanoshell-mediated delivery and laser-triggered release of antisense oligonucleotide and siRNA. ACS Nano. 2012;6:7681-91.
50. Karin M, Cao Y, Greten FR, Li ZW. NF-κB in cancer: from innocent bystander to major culprit. Nat Rev Cancer. 2002;2:301-10. (Pubitemid 37328783)
51. Rouleaua L, Bertia R, Ng VWK, Matteau-Pelletiera C, Lamd T, et al. VCAM-1-targeting gold nanoshell probe for photoacoustic imaging of atherosclerotic plaque in mice. Contrast Media Mol Imaging. 2013;8:27-39.
52. Spivak MY, Bubnov RV, Yemets IM, Lazarenko LM, et al. Gold nanoparticles - the theranostic challenge for PPPM: nanocardiology application. EPMA J. 2013;4:1-17.
53. Smith DM, Simon JK, Baker Jr JR. Applications of nanotechnology for immunology. Nat Rev Immunol. 2013;13:592-605.
54. Melancon MP, Lu W, Yang Z, Zhang R, et al. In vitro and in vivo targeting of hollow gold nanoshells directed at epidermal growth factor receptor for photothermal ablation therapy. Mol Cancer Ther. 2008;7:1730-9.